Agile Development of a Digital Exposure Treatment for Youth With Chronic Musculoskeletal Pain
CompletedNot applicableNCT05079984
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This project proposes to systematically develop and evaluate the feasibility and preliminary effectiveness of a digitally delivered, graded exposure treatment for youth with chronic musculoskeletal pain, utilizing a sequential replicated and randomized single-case experimental design (SCED). SCED provides the opportunity to rigorously evaluate treatment effectiveness at the individual level. Development of iGET Living will be based on a series of short iterations, with alpha testing (Aim 1) on a small sample of adolescents with chronic pain (N = 15). For Aim 1, participants will participate in one session (lasting 2 hours). In Aim 2, Participants will be enrolled in a baseline period ranging from 7-25 days (done to support SCED methodology) after which they will be enrolled in the online intervention program, lasting 6-weeks. Patients will be contacted 3-months post-discharge from treatment (week 22 of enrollment) and will complete self-report outcome measures at this time.
Study details
- Official title
- Agile Development of a Digital Exposure Treatment for Youth With Chronic Musculoskeletal Pain
- Conditions
- Chronic Pain
- Exposure
- Adolescent Behavior
- Child Behavior
- Interventions
- Behavioral: Graded exposure treatment (GET)
- Sponsor
- Stanford University
- Collaborators
- Karolinska Institutet; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- Start date
- 2022-05-02
- Primary completion
- 2025-05-13
- Sex
- All
- Age range
- from 10 Years to 18 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Youth ages 10-18 * Have diagnosis of chronic musculoskeletal pain (\>3months) * Have moderate to high pain interference (PROMIS Pain Interference ≥ 61) * English literate * Have access to computer, smartphone, or tablet with internet connection Exclusion Criteria: * Significant cognitive impairment (e.g., brain injury) * Significant medical or psychiatric problems that would interfere with treatment
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05079984